DE69530553D1 - Medizinisches polymergel - Google Patents

Medizinisches polymergel

Info

Publication number
DE69530553D1
DE69530553D1 DE69530553T DE69530553T DE69530553D1 DE 69530553 D1 DE69530553 D1 DE 69530553D1 DE 69530553 T DE69530553 T DE 69530553T DE 69530553 T DE69530553 T DE 69530553T DE 69530553 D1 DE69530553 D1 DE 69530553D1
Authority
DE
Germany
Prior art keywords
polymer gel
medical polymer
medical
gel
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69530553T
Other languages
English (en)
Other versions
DE69530553T2 (de
Inventor
Masao Tanihara
Hisao Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Application granted granted Critical
Publication of DE69530553D1 publication Critical patent/DE69530553D1/de
Publication of DE69530553T2 publication Critical patent/DE69530553T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
DE69530553T 1994-05-13 1995-05-08 Medizinisches polymergel Expired - Lifetime DE69530553T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12415894 1994-05-13
JP12415894 1994-05-13
PCT/JP1995/000873 WO1995031223A1 (fr) 1994-05-13 1995-05-08 Gel polymere a usage medical

Publications (2)

Publication Number Publication Date
DE69530553D1 true DE69530553D1 (de) 2003-06-05
DE69530553T2 DE69530553T2 (de) 2004-03-25

Family

ID=14878382

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69530553T Expired - Lifetime DE69530553T2 (de) 1994-05-13 1995-05-08 Medizinisches polymergel

Country Status (4)

Country Link
US (2) US5658592A (de)
EP (1) EP0712635B1 (de)
DE (1) DE69530553T2 (de)
WO (1) WO1995031223A1 (de)

Families Citing this family (183)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620436B1 (en) * 1991-10-09 2003-09-16 Lectec Corporation Mixing and dispensing package for a wound dressing
WO1995031223A1 (fr) * 1994-05-13 1995-11-23 Kuraray Co., Ltd. Gel polymere a usage medical
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
EP1806367A3 (de) * 1996-09-19 2007-11-28 The Regents Of The University Of Michigan Polysaccharide wie Alginate oder modifizierte Alginate enthaltende Polymere
ES2317657T3 (es) 1996-09-19 2009-04-16 The Regents Of The University Of Michigan Polimeros que contienen polisacaridos tales como alginatos o alginatos modificados.
US5980883A (en) * 1996-10-02 1999-11-09 Kuraray Co., Ltd. Polymer gel for medical use
EP0914832B1 (de) * 1997-04-04 2006-11-22 Kuraray Co., Ltd. Therapeutisches material für periodontitis
EP0887076A3 (de) * 1997-05-07 1999-03-31 Saturnus A.G. Verhinderung von Gewebeverklebung und ein dafür vorgesehenes endoskopisches System zum Aufblasen einer Körperhöhle
AU2763099A (en) 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
US6703047B2 (en) * 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
ES2241314T3 (es) 1998-08-31 2005-10-16 Cornell Research Foundation, Inc. Monoesteres de acido maleico-dextrano e hidroogeles basados en ellos.
US6692760B2 (en) * 1998-09-06 2004-02-17 Japan Science And Technology Corporation Polymeric material for artificial bone
US6299980B1 (en) 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
US20040043068A1 (en) * 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6379691B1 (en) 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
CN1191093C (zh) * 1998-10-30 2005-03-02 第一制药株式会社 Dds化合物及其测定方法
CA2350628A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
US20020197300A1 (en) * 1999-02-22 2002-12-26 Schultz Clyde L. Drug delivery system for anti-glaucomatous medication
US6410045B1 (en) 1999-02-22 2002-06-25 Clyde Lewis Schultz Drug delivery system for antiglaucomatous medication
JP2002542304A (ja) * 1999-04-28 2002-12-10 ベクトレイムド インコーポレイテッド 酵素的に活性化された重合薬物接合体
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
CA2430501A1 (en) * 2000-01-11 2001-07-19 Intralytix, Inc. Method for produce sanitation using bacteriophages
US6703040B2 (en) 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
DE60137489D1 (de) * 2000-02-03 2009-03-12 Tissuemed Ltd Gerät zum verschliessen einer chirurgischen punktionswunde
DK1259269T3 (da) * 2000-03-03 2008-10-20 Syntacoll Ag Middel til sårbehandling
US6721987B2 (en) * 2000-04-06 2004-04-20 Kimberly-Clark Worldwide, Inc. Dental wipe
US7012169B2 (en) * 2000-04-06 2006-03-14 Kimberly-Clark Worldwide, Inc. Disposable finger sleeve for appendages
US6296867B1 (en) * 2000-04-28 2001-10-02 Gholam A. Peyman Therapeutic contact lens comprising living cells within a matrix
WO2002007674A2 (en) * 2000-07-21 2002-01-31 Ceramoptec Industries, Inc. Enhancing compound penetration into hair follicles
DE50111415D1 (de) * 2000-08-02 2006-12-21 Aesculap Ag & Co Kg Medizintechnisches produkt, verfahren zu seiner herstellung und bereitstellung für die chirurgie
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
WO2002019887A2 (en) * 2000-09-05 2002-03-14 Technion Research And Development Foundation Ltd. Methods of repairing longitudinal bone defects
US20050059031A1 (en) * 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
AU2002226876A1 (en) * 2000-10-06 2002-04-15 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
ATE286408T1 (de) * 2000-10-23 2005-01-15 Tissuemed Ltd Selbstklebende, hydratierbare matrix für therapeutische anwendungen
USD494369S1 (en) 2001-04-04 2004-08-17 Kimberly-Clark Worldwide, Inc. Dental wipe
EP1429689A4 (de) * 2001-09-24 2006-03-08 Medtronic Ave Inc Rationale arzneimitteltherapie-vorrichtung und verfahren
JP4342314B2 (ja) * 2001-12-17 2009-10-14 ユニバーシティ カレッジ カーディフ コンサルタンツ リミテッド 病変部位への特異的送達のための開裂薬剤
MXPA04006438A (es) * 2001-12-31 2005-06-08 Ares Lab Llc Composiciones hemostaticas y metodos para el control de sangrado.
FR2839451B1 (fr) * 2002-05-07 2006-05-05 Oreal Compose comprenant un polymere, un espaceur et un principe actif, composition contenant ce compose et utilisations
AU2003257089A1 (en) * 2002-07-31 2004-02-16 University Of Florida Antimicrobial and antiproteolytic wound dressing
US20070172821A1 (en) * 2002-08-23 2007-07-26 Li-Qun Wu Assembly of chitosan onto an electrode surface
WO2004029096A2 (en) * 2002-09-26 2004-04-08 University Of Maryland Biotechnology Institute Polysaccharide-based polymers and methods of making the same
US6874699B2 (en) * 2002-10-15 2005-04-05 Wisconsin Alumni Research Foundation Methods and apparata for precisely dispensing microvolumes of fluids
EP1556121B1 (de) 2002-10-28 2016-06-01 Northgate Technologies Incorporated Insufflationssystem mit einem Insufflatorschlauch mit mehrfacher Kapazität
IL153699A (en) 2002-12-26 2008-11-26 Prochon Biotech Ltd The composition for transplantation basically
AU2003283785A1 (en) * 2002-11-14 2004-06-03 Prochon Biotech Ltd. Bone enhancing composite
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
US20040236415A1 (en) * 2003-01-02 2004-11-25 Richard Thomas Medical devices having drug releasing polymer reservoirs
US7883615B2 (en) * 2003-02-12 2011-02-08 University Of Maryland, College Park Controlled electrochemical deposition of polysaccharide films and hydrogels, and materials formed therefrom
WO2004075781A2 (en) * 2003-02-26 2004-09-10 Medivas, Llc Bioactive stents and methods for use thereof
US6981552B2 (en) * 2003-03-21 2006-01-03 Halliburton Energy Services, Inc. Well treatment fluid and methods with oxidized polysaccharide-based polymers
US20040243224A1 (en) * 2003-04-03 2004-12-02 Medtronic Vascular, Inc. Methods and compositions for inhibiting narrowing in mammalian vascular pathways
DE602004025217D1 (de) * 2003-04-04 2010-03-11 Tissuemed Ltd
US7654975B2 (en) 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
EP1620138B1 (de) * 2003-04-28 2008-08-06 Johnson & Johnson Medical Ltd. Schmerz-empfindliche therapeutische wundverbände
GB0310721D0 (en) * 2003-05-09 2003-06-11 Bristol Myers Squibb Co Use of a wound dressing in the treatment of pressure sores
CA2525631C (en) * 2003-05-13 2012-12-18 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7704223B2 (en) 2003-10-07 2010-04-27 Northgate Technologies Inc. System and method for delivering a substance to a body cavity
US20060188486A1 (en) * 2003-10-14 2006-08-24 Medivas, Llc Wound care polymer compositions and methods for use thereof
US20070160622A1 (en) * 2005-12-07 2007-07-12 Medivas, Llc Method for assembling a polymer-biologic delivery composition
DE602004031034D1 (de) 2003-10-31 2011-02-24 Trudell Medical Int System zur manipulierung eines katheters für die ablage einer substanz in einer körperhöhle
GB2408207A (en) 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
US7375404B2 (en) * 2003-12-05 2008-05-20 University Of Maryland Biotechnology Institute Fabrication and integration of polymeric bioMEMS
US20050154451A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050149174A1 (en) * 2003-12-18 2005-07-07 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050154455A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050137683A1 (en) * 2003-12-19 2005-06-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050152943A1 (en) * 2003-12-23 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050152940A1 (en) * 2003-12-23 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050152942A1 (en) * 2003-12-23 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20050154452A1 (en) * 2003-12-23 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
WO2005070105A2 (en) * 2004-01-08 2005-08-04 Kevin Marchitto Adhesive laminates for rapid wound occlusion
US20050159809A1 (en) * 2004-01-21 2005-07-21 Medtronic Vascular, Inc. Implantable medical devices for treating or preventing restenosis
US7601546B2 (en) * 2004-02-23 2009-10-13 Systagenix Wound Management (Us), Inc. Diagnostic test devices
GB2422664A (en) * 2005-01-28 2006-08-02 Ethicon Inc Device for detecting an enzyme in a sample
JP4566189B2 (ja) * 2004-03-15 2010-10-20 テルモ株式会社 癒着防止材
WO2005089472A2 (en) * 2004-03-17 2005-09-29 Genzyme Corporation Anti-adhesion spraying
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US20050228490A1 (en) * 2004-04-09 2005-10-13 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
EP1765426A4 (de) * 2004-05-12 2011-07-27 Medivas Llc Wundheilungspolymerzusammensetzungen und verfahren zu ihrer verwendung
US20050261762A1 (en) * 2004-05-21 2005-11-24 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
US7137864B2 (en) * 2004-07-12 2006-11-21 Swanson Melvin J Methods and reagents for treating honeybees for parasitic mites
AU2005268647B2 (en) * 2004-08-03 2011-04-14 Tissuemed Limited Tissue-adhesive materials
GB2418145A (en) * 2004-09-17 2006-03-22 Ethicon Inc Wound treatment system
US20060062822A1 (en) * 2004-09-21 2006-03-23 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
US20060088571A1 (en) * 2004-10-21 2006-04-27 Medtronic Vascular, Inc. Biocompatible and hemocompatible polymer compositions
US8663225B2 (en) 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US7530578B2 (en) * 2004-11-17 2009-05-12 Continental Commercial Products, Llc Step-on receptacle with tip prevention
US7381707B2 (en) * 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
RU2429018C2 (ru) * 2005-07-06 2011-09-20 Сейкагаку Корпорейшн Гель, полученный из фотосшитой гиалуроновой кислоты с введенным лекарственным средством
US20070027530A1 (en) * 2005-07-26 2007-02-01 Medtronic Vascular, Inc. Intraluminal device, catheter assembly, and method of use thereof
US7674058B2 (en) * 2005-08-30 2010-03-09 Kimberly-Clark Worldwide, Inc. Disposable wipe with liquid storage and application system
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
CN101309709A (zh) * 2005-09-21 2008-11-19 苏尔莫迪克斯公司 包含天然生物可降解的多糖的涂层和物品
ATE543522T1 (de) * 2005-09-21 2012-02-15 Surmodics Inc In vivo geformte matrizen mit natürlichen biologisch abbaubaren polysacchariden und ihre ophthalmischen verwendungen
CA2623198C (en) 2005-09-22 2014-08-05 Medivas, Llc Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
US20070067020A1 (en) * 2005-09-22 2007-03-22 Medtronic Vasular, Inc. Intraluminal stent, delivery system, and a method of treating a vascular condition
US8652504B2 (en) * 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
JP2009525109A (ja) 2006-02-03 2009-07-09 ティシューメッド リミテッド 組織接着材料
US20090018575A1 (en) * 2006-03-01 2009-01-15 Tissuemed Limited Tissue-adhesive formulations
US20070231361A1 (en) * 2006-03-28 2007-10-04 Medtronic Vascular, Inc. Use of Fatty Acids to Inhibit the Growth of Aneurysms
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
CA2650473C (en) 2006-04-24 2013-06-18 Incept, Llc Protein crosslinkers, crosslinking methods and applications thereof
WO2007130477A2 (en) * 2006-05-02 2007-11-15 Medivas, Llc Delivery of ophthalmologic agents to the exterior or interior of the eye
JP5196498B2 (ja) * 2006-05-09 2013-05-15 メディバス エルエルシー 生分解性水溶性ポリマー
WO2008015566A2 (en) 2006-08-04 2008-02-07 Northgate, Technologies, Inc. In-dwelling port for access into a body
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
JP5579445B2 (ja) 2007-01-22 2014-08-27 オルソトロフィックス インコーポレイテッド 軟骨形成を促進するペプチド組成物および方法
US8075562B2 (en) * 2007-06-25 2011-12-13 Wisconsin Alumni Research Foundation Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
WO2009015143A1 (en) * 2007-07-24 2009-01-29 Medivas, Llc Biodegradable cationic polymer gene transfer compositions and methods of use
GB0715514D0 (en) * 2007-08-10 2007-09-19 Tissuemed Ltd Coated medical devices
EP2195039B1 (de) 2007-08-28 2016-11-30 Otago Innovation Limited Chirurgisches hydrogel
EP2259803B2 (de) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Vorrichtung zur förderung von hämostase und/oder wundheilung
EP3144346A1 (de) * 2008-04-24 2017-03-22 Medtronic Inc. Rehydratisierbare polysaccharidpartikel
WO2009137689A2 (en) 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
WO2010005850A1 (en) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Methods and compositions for modulating angiogenesis
CN102186484A (zh) * 2008-08-13 2011-09-14 梅迪沃什有限公司 Aabb-聚(酯肽)可生物降解聚合物及其使用方法
WO2010093873A2 (en) 2009-02-12 2010-08-19 Incept, Llc Drug delivery through hydrogel plugs
US8758802B2 (en) 2009-12-14 2014-06-24 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
KR101957625B1 (ko) 2010-06-01 2019-03-12 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
WO2011151384A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
MX352875B (es) 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
TWI398275B (zh) * 2010-07-12 2013-06-11 Agricultural Res Inst 皮膚創傷敷料及其製備方法
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
WO2012104620A2 (en) 2011-01-31 2012-08-09 Systagenix Wound Management Ip Co. B.V. Wound prognosis
GB201116523D0 (en) 2011-09-23 2011-11-09 Systagenix Wound Man Ip Co Bv Wound prognosis
ES2784192T3 (es) * 2011-03-04 2020-09-23 Inst Nat Sante Rech Med Partículas que contienen un factor de crecimiento y usos de las mismas
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP2723800B1 (de) 2011-06-23 2015-10-07 DSM IP Assets B.V. Mikro- oder nanopartikel mit einem biologisch abbaubaren polyesteramid-copolymer zur verwendung bei der verabreichung von bioaktiven substanzen
FR2979072B1 (fr) * 2011-08-16 2013-09-27 Lentilles Procede, dispositif et piece composite pour la fabrication d'une lentille hybride
US8932623B2 (en) * 2011-08-25 2015-01-13 Ethicon, Inc. Protective wound dressing device for oral and pharyngeal space
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
CA2851321C (en) 2011-10-11 2020-07-07 Baxter International Inc. Hemostatic compositions
ES2553702T3 (es) 2011-10-27 2015-12-11 Baxter International Inc Composiciones hemostáticas
EP2787973B1 (de) 2011-12-05 2019-10-09 Incept, LLC Medizinische organogelprozesse und -zusammensetzungen
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
US9375519B2 (en) 2012-06-25 2016-06-28 Surmodics, Inc. Bioerodable poly(etheresteramides) and medical article uses
US9579388B2 (en) 2012-11-29 2017-02-28 Rene Gauthier System and method for alleviating the appearance of scars and/or scar tissue
NL2010040C2 (en) * 2012-12-21 2014-06-24 Internat Inst For Diagnostic And Analitical Affairs B V Cleavable coating material having microbial functionality.
CA2904657C (en) 2013-03-14 2021-02-16 The University Of Massachusetts Methods of inhibiting cataracts and presbyopia
CN105611914B (zh) * 2013-06-19 2020-09-08 加利福尼亚大学董事会 局部递送治疗剂的化学构造物
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US20180271800A1 (en) 2017-03-24 2018-09-27 E Ink California, Llc Microcell systems for delivering active molecules
CN105828844B (zh) 2013-12-11 2019-09-27 弗罗桑医疗设备公司 包含挤出增强剂的干组合物
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
WO2015139025A1 (en) * 2014-03-14 2015-09-17 The Regents Of The University Of California Tco conjugates and methods for delivery of therapeutic agents
US20160051723A1 (en) * 2014-08-21 2016-02-25 Gregory J. Pomrink Bioresorbable tissue repair composition
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
EP3233067B1 (de) 2014-12-18 2019-11-06 DSM IP Assets B.V. Arzneimittelabgabesystem zur abgabe von säureempfindlichen arzneimitteln
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
CN104744716B (zh) * 2015-04-03 2018-03-09 广州康华微创生物科技有限公司 一种壳聚糖与改性聚乙烯醇复合膜的制备方法
EP3302588A4 (de) 2015-05-29 2019-01-23 Launchpad Medical, LLC Zusammensetzungen und verfahren zur haftung auf oberflächen
NO344096B1 (en) * 2015-06-03 2019-09-02 Ewos Innovation As Oral delivery system for bioactive active agents
EP3302445A1 (de) 2015-06-03 2018-04-11 Ewos Innovation AS Orales freisetzungssystem für bioaktive wirkstoffe
BR112017027695A2 (pt) 2015-07-03 2018-09-04 Ferrosan Medical Devices As seringa para retenção e mistura de primeira e segunda substâncias
WO2017044983A1 (en) 2015-09-10 2017-03-16 Shasqi, Inc. Bioorthogonal compositions
SG11201803606XA (en) 2015-11-13 2018-05-30 Univ Massachusetts Bifunctional molecules containing peg for use in inhibiting cataracts and presbyopia
AR111190A1 (es) 2017-03-22 2019-06-12 Genentech Inc Composiciones en hidrogel de prodrogas entrecruzadas de ácido hialurónico y métodos relacionados
AU2018250312B2 (en) 2017-04-07 2022-03-17 Tambo, Inc. Bioorthogonal compositions
JOP20190245A1 (ar) 2017-04-20 2019-10-15 Novartis Ag أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
US20200268931A1 (en) * 2017-09-13 2020-08-27 Tazuke Kofukai Brain damage recovery material
WO2019099323A1 (en) * 2017-11-14 2019-05-23 E Ink California, Llc Microcell systems for delivering hydrophilic active molecules
CN111295182A (zh) 2017-11-14 2020-06-16 伊英克加利福尼亚有限责任公司 包括多孔导电电极层的电泳活性物质递送系统
EP3770180A4 (de) * 2018-03-22 2021-12-22 Mochida Pharmaceutical Co., Ltd. An eine nichtsteroidale entzündungshemmende verbindung gebundenes alginsäurederivat
CA3097819A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
KR20220074962A (ko) 2019-11-27 2022-06-03 이 잉크 캘리포니아 엘엘씨 전기 침식 밀봉층을 갖는 마이크로셀들을 포함하는 유익제 전달 시스템
CN111057252B (zh) * 2020-01-06 2022-11-25 陕西科技大学 一种可控去除的强粘附型水凝胶及其制备方法
CN111269332A (zh) * 2020-03-27 2020-06-12 广州古泉生物科技有限公司 一种壳聚糖-海藻酸钠水凝胶的制备和应用
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN112007200B (zh) * 2020-08-12 2021-10-01 山东百多安医疗器械股份有限公司 一种抗菌促修复止血防粘连膜及其制备方法
EP4236926A1 (de) 2020-10-29 2023-09-06 E Ink California, LLC Mikrozellensysteme zur abgabe von vorteilhaften mitteln
WO2022093547A1 (en) 2020-10-29 2022-05-05 E Ink California, Llc Microcell systems for delivering hydrophilic active molecules

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51149883A (en) * 1975-06-19 1976-12-23 Sumitomo Chem Co Ltd Hydrophilic gel
US4226232A (en) * 1979-04-09 1980-10-07 Spenco Medical Corporation Wound dressing
DE3172839D1 (en) * 1980-09-11 1985-12-12 Atomic Energy Authority Uk Improvements in or relating to composite materials
JPS60130601A (ja) * 1983-12-15 1985-07-12 バイオマトリツクス，インコ−ポレイテツド ヒアルロン酸水不溶性組成物の製法
US4588525A (en) * 1984-02-27 1986-05-13 Molecular Biosystems, Inc. Prodrug compounds for dermal application
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
WO1995031223A1 (fr) * 1994-05-13 1995-11-23 Kuraray Co., Ltd. Gel polymere a usage medical

Also Published As

Publication number Publication date
EP0712635A4 (de) 2000-03-29
DE69530553T2 (de) 2004-03-25
EP0712635A1 (de) 1996-05-22
EP0712635B1 (de) 2003-05-02
WO1995031223A1 (fr) 1995-11-23
US5770229A (en) 1998-06-23
US5658592A (en) 1997-08-19

Similar Documents

Publication Publication Date Title
DE69530553D1 (de) Medizinisches polymergel
DE69719154T2 (de) Medizinisches Gerät
DK0906129T3 (da) Implanterbar medicinsk anordning
BR9505605A (pt) Dispositivo cirúrgico
DE69521899T2 (de) Polymerisationsverfahren
DE69606550T2 (de) Medizinischen verbindungsanordnung
NO964106D0 (no) Spröyte
DK0747069T3 (da) Implanterbar medicinsk anordning
DE69522528D1 (de) Kathetereinfuehrsystem
DK0907384T3 (da) Medicinsk anordning
DE59502139D1 (de) Superabsorbierende Polymerisate
DE69503146D1 (de) Sterilisierbare, sauerstoffundurchlässige polymerfilme
DE69429543T2 (de) Koagulationszange
DE69620359T2 (de) Chirurgischer Verband
DE69517549D1 (de) Polymerfilm
DE69524487D1 (de) Sterilisiervorrichtung
DE69532478D1 (de) Polymerfilm
ITMI950222A0 (it) Tessuto
DE59504209D1 (de) Implantierbares medizinisches Gerät
DK48194A (da) Medicinsk elektrode
KR960030492U (ko) 의료용 멸균기
BR9503177A (pt) Gel dental
KR950022733U (ko) 세척기
BR7401896U (pt) Unidade móvel médico odontológica
KR960000467U (ko) 일회용 의료 응급처치 세트

Legal Events

Date Code Title Description
8364 No opposition during term of opposition